

Despite major advances in small molecule drug development, most disease relevant proteins remain beyond the reach of conventional therapeutics. Molecular glues offer a promising solution by inducing novel protein–protein interactions that enable degradation, stabilization, or functional modulation of previously undruggable targets.
This white paper examines emerging, systematic screening and validation strategies to streamline and accelerate molecular glue discovery.

Copyright © 2026 American Chemical Society | 1155 Sixteenth Street NW | Washington, DC 20036 | View our Privacy Policy